The Oncology Institute Execs to Present at Three Healthcare Conferences in March
Event summary
- The Oncology Institute (NASDAQ: TOI) will present at three investor conferences in March 2026.
- CEO Dr. Daniel Virnich and CFO Rob Carter will lead presentations at Jefferies, Leerink, and Oppenheimer events.
- Conferences include both in-person (Miami) and virtual formats.
- TOI operates over 100 clinics across five states, serving ~1.9 million patients.
The big picture
The Oncology Institute's participation in multiple investor conferences underscores its push to highlight its value-based care model amid increasing consolidation in community oncology. With over 100 clinics, TOI is positioning itself as a scalable alternative to hospital-based cancer care, a trend gaining traction as payers demand cost-effective solutions. The virtual and in-person formats reflect the hybrid engagement strategy now common among healthcare investors.
What we're watching
- Investor Sentiment
- How TOI's conference presentations will impact investor perception of its value-based oncology model.
- Expansion Strategy
- Whether TOI can sustain its growth trajectory across five states while maintaining care quality.
- Competitive Positioning
- The pace at which TOI differentiates itself in the crowded community oncology space.
Related topics